The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.
In a new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day Dexcom G7 integrated continuous glucose monitor (CGM) in ...
A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked technology and education as having larger impacts when it comes | Dexcom ...
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
DexCom, Inc, a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring ... a remote monitoring system; Dexcom Real-Time API, which ...
He described how the system, which consists of two ... Its wearable devices, like the Dexcom G6 and G7, provide real-time glucose monitoring without finger pricks, transmitting data to smartphones ...
Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of DexCom in a research note issued to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results